BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37409128)

  • 1. IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation.
    Lee J; Lee K; Bae H; Lee K; Lee S; Ma J; Jo K; Kim I; Jee B; Kang M; Im SJ
    Front Immunol; 2023; 14():1117092. PubMed ID: 37409128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell Receptor Diversity and Lineage Relationship between Virus-Specific CD8 T Cell Subsets during Chronic Lymphocytic Choriomeningitis Virus Infection.
    Chang YM; Wieland A; Li ZR; Im SJ; McGuire DJ; Kissick HT; Antia R; Ahmed R
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade.
    Jadhav RR; Im SJ; Hu B; Hashimoto M; Li P; Lin JX; Leonard WJ; Greenleaf WJ; Ahmed R; Goronzy JJ
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14113-14118. PubMed ID: 31227606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and anatomic location of PD-1
    Im SJ; Obeng RC; Nasti TH; McManus D; Kamphorst AO; Gunisetty S; Prokhnevska N; Carlisle JW; Yu K; Sica GL; Cardozo LE; Gonçalves ANA; Kissick HT; Nakaya HI; Ramalingam SS; Ahmed R
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2221985120. PubMed ID: 37782797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.
    Viramontes KM; Neubert EN; DeRogatis JM; Tinoco R
    Front Immunol; 2022; 13():869768. PubMed ID: 35774790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
    Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
    Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection.
    Im SJ; Konieczny BT; Hudson WH; Masopust D; Ahmed R
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4292-4299. PubMed ID: 32034098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Lymphocytic Choriomeningitis Virus Strain Sustains Abundant Exhausted Progenitor CD8 T Cells without Systemic Viremia.
    Beura LK; Scott MC; Pierson MJ; Joag V; Wijeyesinghe S; Semler MR; Quarnstrom CF; Busman-Sahay K; Estes JD; Hamilton SE; Vezys V; O'Connor DH; Masopust D
    J Immunol; 2022 Nov; 209(9):1691-1702. PubMed ID: 36122933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsets of exhausted CD8
    Miller BC; Sen DR; Al Abosy R; Bi K; Virkud YV; LaFleur MW; Yates KB; Lako A; Felt K; Naik GS; Manos M; Gjini E; Kuchroo JR; Ishizuka JJ; Collier JL; Griffin GK; Maleri S; Comstock DE; Weiss SA; Brown FD; Panda A; Zimmer MD; Manguso RT; Hodi FS; Rodig SJ; Sharpe AH; Haining WN
    Nat Immunol; 2019 Mar; 20(3):326-336. PubMed ID: 30778252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion.
    Ahn E; Youngblood B; Lee J; Lee J; Sarkar S; Ahmed R
    J Virol; 2016 Oct; 90(19):8934-46. PubMed ID: 27466420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection.
    Gabriel SS; Tsui C; Chisanga D; Weber F; Llano-León M; Gubser PM; Bartholin L; Souza-Fonseca-Guimaraes F; Huntington ND; Shi W; Utzschneider DT; Kallies A
    Immunity; 2021 Aug; 54(8):1698-1714.e5. PubMed ID: 34233154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.
    Richter K; Agnellini P; Oxenius A
    Int Immunol; 2010 Jan; 22(1):13-23. PubMed ID: 19880580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
    Jin HT; Anderson AC; Tan WG; West EE; Ha SJ; Araki K; Freeman GJ; Kuchroo VK; Ahmed R
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14733-8. PubMed ID: 20679213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor progenitor exhausted CD8
    Lan X; Mi T; Alli S; Guy C; Djekidel MN; Liu X; Boi S; Chowdhury P; He M; Zehn D; Feng Y; Youngblood B
    Nat Immunol; 2024 Jun; 25(6):1046-1058. PubMed ID: 38816618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYB orchestrates T cell exhaustion and response to checkpoint inhibition.
    Tsui C; Kretschmer L; Rapelius S; Gabriel SS; Chisanga D; Knöpper K; Utzschneider DT; Nüssing S; Liao Y; Mason T; Torres SV; Wilcox SA; Kanev K; Jarosch S; Leube J; Nutt SL; Zehn D; Parish IA; Kastenmüller W; Shi W; Buchholz VR; Kallies A
    Nature; 2022 Sep; 609(7926):354-360. PubMed ID: 35978192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling Virus-Specific Tcf1+ T Cell Repertoires During Acute and Chronic Viral Infection.
    Yermanos A; Sandu I; Pedrioli A; Borsa M; Wagen F; Oetiker N; Welten SPM; Pallmer K; Reddy ST; Oxenius A
    Front Immunol; 2020; 11():986. PubMed ID: 32547546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1
    Humblin E; Korpas I; Lu J; Filipescu D; van der Heide V; Goldstein S; Vaidya A; Soares-Schanoski A; Casati B; Selvan ME; Gümüş ZH; Wieland A; Corrado M; Cohen-Gould L; Bernstein E; Homann D; Chipuk J; Kamphorst AO
    Sci Immunol; 2023 Aug; 8(86):eadg0878. PubMed ID: 37624910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors.
    Lee M; Im SK; Baek S; Ji M; Kim M; Lee EJ; Ji ST; Ferrando-Martinez S; Wolfarth A; Lee JY; Kim D; Choi D
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38471713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Intrinsic CD38 Expression Sustains Exhausted CD8
    DeRogatis JM; Neubert EN; Viramontes KM; Henriquez ML; Nicholas DA; Tinoco R
    J Virol; 2023 Apr; 97(4):e0022523. PubMed ID: 37039663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.